Japan, February 9, 2006 - Astellas Pharma Inc. ("Astellas"; headquarters: Tokyo; President and CEO: Toichi Takenaka) today announced a following statement with regard to the news appeared on the front page of the day's morning edition of Asahi Shimbun titled as "Acquisition of Zepharma Inc."

"Although Astellas always studies every possible opportunity to maximize its business value, Astellas has made no concrete decision, including sell-off of Zepharma Inc. to Taisho Pharmaceutical Co, Ltd."

Contact the Media Relations team
Corporate Advocacy & Relations
Main phone line for Media: +81-3244-3201 
Business hours (JST)
From Monday to Thursday: 8:45 am to 5:45 pm, Friday: 8:45 am to 4:00 pm
(closed on Saturdays, Sundays, national holidays and company holidays)